C9orf72 and amyotrophic lateral sclerosis: A postmortem study revealed a higher prevalence of GVD in ALS/FTLD-TDP patients with C9orf72 hexanucleotide expansion than in nonmutated ALS/FTLD-TDP patients or age-matched controls [91].